Shield Therapeutics's market cap is currently £84.94M. The company's EPS TTM is p-0.0074335515; its P/E ratio is ―; Shield Therapeutics is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
